Dr Toinét Cronjé, Director of Translational Sciences at Sequoia Genetics, will be attending ESC Congress 2025, the largest annual gathering of cardiovascular professionals worldwide.
ESC Congress brings together over 30,000 experts in cardiology to explore cutting-edge science, clinical advancements, and emerging therapies in cardiovascular disease. With a strong focus on translating research into improved patient care, this year’s programme highlights innovation across cardiometabolic therapeutics.
We support our pharmaceutical, biotech, and investor partners by applying genetic and multi-omics evidence to inform drug development strategies in cardiovascular and metabolic diseases. Participation in ESC ensures we remain aligned with the latest insights, unmet needs, and future directions in the field.
To learn more about ESC Congress 2025, visit the official event page here.